Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUTYLSCOPOLAMINE vs CABAZITAXEL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUTYLSCOPOLAMINE vs CABAZITAXEL: Safety Overview

Metric BUTYLSCOPOLAMINE CABAZITAXEL
Total FAERS Reports 851 2,553
Deaths Reported 99 467
Death Rate 11.6% 18.3%
Hospitalizations 344 950
Average Patient Age 45.0 yrs 68.7 yrs
% Female Patients 75.4% 2.0%
FDA Approval Date N/A Dec 29, 2021
Manufacturer N/A Sanofi-Aventis U.S. LLC
Marketing Status N/A Prescription